Status:

COMPLETED

Enhancing Mental Health Outcomes for Patients With Psychosis in Malawi Through Community-based Rehabilitation

Lead Sponsor:

University of North Carolina, Chapel Hill

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

Psychosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The overall aim of the proposed study is to determine the feasibility, acceptability, fidelity, and preliminary effectiveness of the adapted nurse-led, community-based rehabilitation treatment model f...

Detailed Description

Psychosis exacts a heavy morbidity and mortality toll worldwide, but especially in low- and middle-income countries (LMICs). Psychotic disorders are one of the most common presenting complaints for in...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for PWLE:
  • Current outpatient at Queen Elizabeth Central Hospital psychiatry clinic
  • Age 18 or older
  • Diagnosis of schizophrenia spectrum disorder or clinical presentation of symptoms of hallucinations, delusions or thought disorder that persisted for longer than one month and are accompanied by significant functional impairment
  • Resident in Blantyre District
  • Not planning to relocate out of Blantyre District in next 12 months
  • Has a primary caregiver willing to participate in the study
  • Has current elevated symptoms or poor functioning as demonstrated by one or more of:
  • Positive and Negative Symptoms Scale score ≥58
  • WHO Disability Assessment Schedule 2.0 score ≥35
  • Clinical Global Impression Severity score ≥2 (at least mildly ill)
  • Inclusion Criteria for Caregivers:
  • Is a current caregiver for an eligible and consenting patient participant.
  • Age 18 or older
  • Resident in Blantyre District
  • Not planning to relocate out of Blantyre District in next 12 months
  • Exclusion Criteria for PWLE:
  • Not a current outpatient at Queen Elizabeth Central Hospital psychiatry clinic
  • Not Age 18 or older
  • No diagnosis of schizophrenia spectrum disorder or clinical presentation of symptoms of hallucinations, delusions or thought disorder that persisted for longer than one month and are accompanied by significant functional impairment
  • Not a resident in Blantyre District
  • Planning to relocate out of Blantyre District in next 12 months
  • Does not have a primary caregiver willing to participate in the study
  • Does not have current elevated symptoms or poor functioning as demonstrated by one or more of:
  • Positive and Negative Symptoms Scale score ≥58
  • WHO Disability Assessment Schedule 2.0 score ≥35
  • Clinical Global Impression Severity score ≥2 (at least mildly ill)
  • Exclusion Criteria for Caregivers:
  • Is not a current caregiver for an eligible and consenting patient participant.
  • Not Age 18 or older
  • Not a resident in Blantyre District
  • Planning to relocate out of Blantyre District in next 12 months

Exclusion

    Key Trial Info

    Start Date :

    December 4 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    August 31 2025

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT06080477

    Start Date

    December 4 2023

    End Date

    August 31 2025

    Last Update

    September 22 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Queen Elizabeth Central Hosptial

    Blantyre, Malawi